The Cross-Over Study to Investigate the Effect of Proton Pump Inhibitor on the Pharmacokinetics and Pharmacodynamics of Metformin in Healthy Korean Men.

Trial Profile

The Cross-Over Study to Investigate the Effect of Proton Pump Inhibitor on the Pharmacokinetics and Pharmacodynamics of Metformin in Healthy Korean Men.

Completed
Phase of Trial: Phase I

Latest Information Update: 16 Dec 2014

At a glance

  • Drugs Metformin (Primary) ; Pantoprazole; Rabeprazole
  • Indications Duodenal ulcer; Dyspepsia; Erosive oesophagitis; Gastric ulcer; Gastritis; Gastro-oesophageal reflux; Heartburn; Helicobacter infections; Pancreatitis; Peptic ulcer; Reflux oesophagitis; Type 2 diabetes mellitus; Zollinger-Ellison syndrome
  • Focus Pharmacokinetics
  • Acronyms MPI
  • Most Recent Events

    • 27 May 2013 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top